InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,495.52
(
0.45%
)
US TECH 100
18,331.60
(
0.84%
)
Dow Jones
40,736.96
(
-0.23%
)
Brent Oil
69.46
(
-0.11%
)
Bitcoin
56,742.12
(
-1.61%
)
Post# of 6306
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

TheHound

Send PM Follow Ignore
Followers 71
Posts 9472
Boards Moderated 0
Alias Born 07/17/2013

TheHound

Re: DDobserver post# 5625

Thursday, 11/17/2016 12:06:40 PM

Thursday, November 17, 2016 12:06:40 PM

Post# of 6306
wrong. the minimum bid price requirement stems from Section 5550(a)(2) of the Nasdaq's Equity Rules guide. It clearly states: "(a) Continued Listing Requirements for Primary Equity Securities: (2) Minimum bid price of at least $1 per share."

I have spent hundreds of hours over the past three years completing due diligence on Invivo Therapeutics.... It is also correct that this stock must stay at $4p/s to remain within the NASDQ listing that it currently has...

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up